Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Current Topics in Microbiology and Immunology|April 17, 2010
CXCR4 in clinical hematologyGary Calandra, Gary Bridger, Simon Fricker
FEBS Letters|September 11, 2002
Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4Sigrid Hatse, Katrien Princen, Gary Bridger, et al.
Blood|January 28, 2006
Mobilization as a preparative regimen for hematopoietic stem cell transplantationJing Chen, André Larochelle, Simon Fricker, et al.
Molecular Pharmacology|September 5, 2008
Comparison of the potential multiple binding modes of bicyclam, monocylam, and noncyclam small-molecule CXC chemokine receptor 4 inhibitorsRebecca S Y Wong, Veronique Bodart, Markus Metz, et al.
Leukemia Research|April 4, 2007
Effects of AMD3100 on transmigration and survival of acute myelogenous leukemia cellsJane L Liesveld, Jeremy Bechelli, Karen Rosell, et al.
Antimicrobial Agents and Chemotherapy|April 30, 2008
Suppression of dualtropic human immunodeficiency virus type 1 by the CXCR4 antagonist AMD3100 is associated with efficiency of CXCR4 use and baseline virus compositionSigne Fransen, Gary Bridger, Jeannette M Whitcomb, et al.
Immunity|October 18, 2003
Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescenceCoralie Martin, Peter C E Burdon, Gary Bridger, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 10, 2009
Successful stem cell remobilization using plerixafor (mozobil) plus granulocyte colony-stimulating factor in patients with non-hodgkin lymphoma: results from the plerixafor NHL phase 3 study rescue protocolIvana N Micallef, Patrick J Stiff, John F DiPersio, et al.
Pharmacology & Therapeutics|July 13, 2005
The therapeutic potential in targeting CCR5 and CXCR4 receptors in infectious and allergic pulmonary diseaseCory M Hogaboam, Kristin J Carpenter, Jane M Schuh, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 27, 2003
Increased matrix metalloproteinase activity after canine cardiopulmonary bypass is suppressed by a nitric oxide scavengerIrvin Mayers, Thomas Hurst, Anna Radomski, et al.
Pageof 4